Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONCT Oncternal Therapeutics, Inc.

盘前交易 07-02 06:22:47 EDT

7.02

-0.58

-7.70%

最高7.83	最低6.92	成交量5,448
今开7.01	昨收7.60	日振幅11.97%
总市值2,076万	流通市值1,898万	总股本295.96万
成交额3.89万	换手率0.20%	流通股本270.57万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONCT","market":"US","secType":"STK","nameCN":"Oncternal Therapeutics, Inc.","latestPrice":7.015,"timestamp":1719864000000,"preClose":7.6,"halted":0,"volume":5448,"delay":0,"floatShares":2705697,"shares":2959645,"eps":-12.339523,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.585,"latestTime":"07-02 06:22:47 EDT","open":7.01,"high":7.83,"low":6.92,"amount":38859.2639496,"amplitude":0.119737,"askPrice":10.92,"askSize":100,"bidPrice":6.74,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-12.339523,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1719927000000},"adr":0,"listingDate":1075784400000,"adjPreClose":6.87,"postHourTrading":{"tag":"盘后","latestPrice":7.015,"preClose":7.015,"latestTime":"19:44 EDT","volume":2,"amount":14.01,"timestamp":1719877495335},"volumeRatio":0.8558233111679494,"impliedVol":3.9363,"impliedVolPercentile":0.5407},"requestUrl":"/m/hq/s/ONCT/wiki","defaultTab":"wiki","newsList":[{"id":"2448291204","title":"Oncternal Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.07%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448291204","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448291204?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:50","pubTimestamp":1719849010,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时50分，Oncternal Therapeutics, Inc.股票出现波动，股价急速跳水5.07%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701235010941f2c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701235010941f2c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2446825866","title":"Oncternal Therapeutics, Inc.盘中异动 早盘股价大跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446825866","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446825866?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:30","pubTimestamp":1719329422,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日23时30分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅下跌5.84%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.90%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为313.47%、191.83%、164.76%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.、Effector Therapeutics, Inc.，振幅分别为67.71%、42.80%、34.28%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625233022941f0f74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625233022941f0f74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2443608151","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨5.83%报8.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443608151","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443608151?lang=zh_cn&edition=full","pubTime":"2024-06-15 00:42","pubTimestamp":1718383342,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日00时42分，Oncternal Therapeutics, Inc.股票出现异动，股价急速上涨5.83%。截至发稿，该股报8.78美元/股，成交量2995股，换手率0.10%，振幅1.57%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615004222941eeb5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615004222941eeb5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2442882991","title":"Oncternal Therapeutics, Inc.盘中异动 快速拉升6.21%报8.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442882991","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442882991?lang=zh_cn&edition=full","pubTime":"2024-06-11 00:23","pubTimestamp":1718036630,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日00时23分，Oncternal Therapeutics, Inc.股票出现异动，股价快速拉升6.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611002350aef42d27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611002350aef42d27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2441209955","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441209955","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441209955?lang=zh_cn&edition=full","pubTime":"2024-06-06 00:55","pubTimestamp":1717606533,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日00时55分，Oncternal Therapeutics, Inc.股票出现异动，股价急速上涨5.30%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Kineta, Inc.、Rezolute, Inc.、诺瓦瓦克斯医药涨幅较大，Cns Pharmaceuticals, Inc.、Virios Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为124.17%、63.57%、51.43%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为66.83%、63.28%、54.10%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606005533aef39343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606005533aef39343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2440414758","title":"Oncternal Therapeutics, Inc.盘中异动 下午盘快速跳水5.54%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440414758","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440414758?lang=zh_cn&edition=full","pubTime":"2024-06-04 03:22","pubTimestamp":1717442522,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日03时22分，Oncternal Therapeutics, Inc.股票出现波动，股价快速下跌5.54%。截至发稿，该股报8.70美元/股，成交量1775股，换手率0.06%，振幅0.98%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406040322029f163184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406040322029f163184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2439586550","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨5.10%报9.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439586550","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439586550?lang=zh_cn&edition=full","pubTime":"2024-05-29 02:04","pubTimestamp":1716919459,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日02时04分，Oncternal Therapeutics, Inc.股票出现异动，股价急速上涨5.10%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.97%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Mustang Bio, Inc.、Exicure, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为72.14%、60.30%、44.83%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Exicure, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为89.11%、77.67%、46.86%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529020420968104a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529020420968104a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2437213612","title":"Oncternal Therapeutics, Inc.盘中异动 急速上涨5.69%报9.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437213612","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437213612?lang=zh_cn&edition=full","pubTime":"2024-05-23 00:23","pubTimestamp":1716395001,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日00时23分，Oncternal Therapeutics, Inc.股票出现异动，股价快速上涨5.69%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Igm Biosciences, Inc.、Compugen医疗涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃，换手率分别为326.73%、152.44%、44.48%，振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts ，振幅分别为61.52%、57.14%、48.75%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523002322af89b1d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523002322af89b1d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2436816631","title":"Oncternal Therapeutics, Inc.2024财年第一财季实现净利润-8.39百万美元，同比增加26.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436816631","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436816631?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:16","pubTimestamp":1716048992,"startTime":"0","endTime":"0","summary":"3月31日，Oncternal Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-8.39百万美元，同比增加26.98%；其中营业收入为569000.00美元，同比增加180.30%，每股基本收益为-2.83美元。从资产负债表来看，Oncternal Therapeutics, Inc.总负债6.22百万美元，其中短期债务179000.00美元，资产负债比为4.69，流动比率为4.66。机构评级：截至2024年3月31日，当前有3家机构对Oncternal Therapeutics, Inc.目标价做出预测，其中目标均价为27.67美元，其中最低目标价为19.00美元，最高目标价为39.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190016368b15eb93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190016368b15eb93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","LENZ"],"gpt_icon":0},{"id":"2435512995","title":"Oncternal Therapeutics, Inc.盘中异动 急速拉升5.81%报9.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435512995","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435512995?lang=zh_cn&edition=full","pubTime":"2024-05-14 22:25","pubTimestamp":1715696755,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日22时25分，Oncternal Therapeutics, Inc.股票出现异动，股价快速上涨5.81%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。该信息摘要如下：HC Wainwright & Co.：维持Oncternal Therapeutics评级，由买入调整至买入评级, 目标价由28.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514222556861ed1db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514222556861ed1db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2435378254","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨7.59%报8.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435378254","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435378254?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:31","pubTimestamp":1715607089,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时31分，Oncternal Therapeutics, Inc.股票出现波动，股价急速拉升7.59%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。该信息摘要如下：HC Wainwright & Co.：维持Oncternal Therapeutics评级，由买入调整至买入评级, 目标价由28.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132131298b01b215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132131298b01b215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2435432267","title":"HC Wainwright & Co.：维持Oncternal Therapeutics(ONCT.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435432267","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435432267?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:16","pubTimestamp":1715602612,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Oncternal Therapeutics(ONCT.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513201657876210b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513201657876210b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","LENZ"],"gpt_icon":0},{"id":"2434866799","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434866799","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434866799?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:53","pubTimestamp":1715356403,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时53分，Oncternal Therapeutics, Inc.股票出现异动，股价快速下跌6.20%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510235323792709f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510235323792709f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2433454768","title":"Oncternal Therapeutics Inc    预计每股亏损 2.88 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433454768","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433454768?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:06","pubTimestamp":1715130401,"startTime":"0","endTime":"0","summary":"   * Oncternal Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司的营收将从去年同期的20.3万美元下降13.0%，至17.667万美元。* LSEG 的分析师平均预计 Oncternal Therapeutics Inc 每股亏损 2.88 美元。* 华尔街对 Oncternal Therapeutics Inc 的 12 个月目标价中位数为 28.00 美元，高于其最新收盘价 8.52 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ONCT"],"gpt_icon":0},{"id":"2433359587","title":"Oncternal Therapeutics, Inc.盘中异动 急速下挫8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433359587","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433359587?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:55","pubTimestamp":1715104550,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时55分，Oncternal Therapeutics, Inc.股票出现波动，股价急速跳水8.11%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015550861eb862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015550861eb862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2433479314","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433479314","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433479314?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:31","pubTimestamp":1715002262,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时31分，Oncternal Therapeutics, Inc.股票出现异动，股价急速下跌5.55%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Tc Biopharm  Plc、Effector Therapeutics Inc C/Wts 31/12/2025 、Entera Bio Ltd.涨幅较大，Allarity Therapeutics, Inc.、Tc Biopharm  Plc、Plus Therapeutics, Inc.较为活跃，换手率分别为480.37%、138.92%、39.43%，振幅较大的相关个股有Passage Bio, Inc.、Dianthus Therapeutics, Inc.、BioCryst制药，振幅分别为11.45%、7.09%、5.62%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062131028ae1633c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062131028ae1633c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2432998466","title":"Oncternal Therapeutics, Inc.盘中异动 临近午盘股价大涨5.23%报8.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432998466","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432998466?lang=zh_cn&edition=full","pubTime":"2024-05-02 23:58","pubTimestamp":1714665509,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日23时58分，Oncternal Therapeutics, Inc.股票出现异动，股价急速拉升5.23%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 、Aptevo Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为3955.04%、613.69%、149.73%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Context Therapeutics Inc.，振幅分别为140.88%、70.86%、38.23%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050223583087e855c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050223583087e855c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2431317422","title":"Oncternal Therapeutics Inc    预计每股亏损 2.88 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431317422","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431317422?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:21","pubTimestamp":1714476069,"startTime":"0","endTime":"0","summary":"   * Oncternal Therapeutics Inc    预计将在5月2日公布截至2024年3月31日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的20.3万美元下降13.0%，至17.667万美元。* LSEG 的分析师平均预计 Oncternal Therapeutics Inc 每股亏损 2.88 美元。* 华尔街对 Oncternal Therapeutics Inc 的 12 个月目标价中位数为 28.00 美元，高于其最新收盘价 8.48 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ONCT"],"gpt_icon":0},{"id":"2431845997","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨8.03%报8.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431845997","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431845997?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:42","pubTimestamp":1714416169,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日02时42分，Oncternal Therapeutics, Inc.股票出现波动，股价急速拉升8.03%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Zura Bio Limited C/Wts 、Scorpius Holdings, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Annovis Bio, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1015.74%、78.67%、63.27%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Annovis Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为98.32%、79.12%、75.06%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300242497a57561a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300242497a57561a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2430284039","title":"Oncternal Therapeutics, Inc.盘中异动 早盘股价大涨5.21%报8.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430284039","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430284039?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:30","pubTimestamp":1714055448,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时30分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅上涨5.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.66%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc是一家临床阶段的肿瘤公司，开发一流的新颖疗法，用来针对广泛的癌症和大量未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522304879237b41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522304879237b41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncternal.com","stockEarnings":[{"period":"1week","weight":-0.1263},{"period":"1month","weight":-0.2383},{"period":"3month","weight":-0.2433},{"period":"6month","weight":-0.293},{"period":"1year","weight":0.0167},{"period":"ytd","weight":-0.3459}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oncternal Therapeutics, Inc.是一家特拉华州公司，于1997年9月24日注册成立。该公司是一家临床阶段的生物制药公司，专注于开发新型肿瘤疗法，用于治疗具有关键未满足医疗需求的癌症患者。Oncternal追求药物开发，靶向与癌症产生或进展有关的有希望但尚未开发的生物学途径，重点关注前列腺癌和血液系统恶性肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.063855},{"month":2,"riseRate":0.3,"avgChangeRate":-0.022486},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.033532},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.026101},{"month":5,"riseRate":0.52381,"avgChangeRate":0.062298},{"month":6,"riseRate":0.428571,"avgChangeRate":0.011229},{"month":7,"riseRate":0.380952,"avgChangeRate":-0.037314},{"month":8,"riseRate":0.5,"avgChangeRate":-0.020143},{"month":9,"riseRate":0.45,"avgChangeRate":-0.013715},{"month":10,"riseRate":0.4,"avgChangeRate":-0.016721},{"month":11,"riseRate":0.5,"avgChangeRate":0.033896},{"month":12,"riseRate":0.5,"avgChangeRate":0.019072}],"exchange":"NASDAQ","name":"Oncternal Therapeutics, Inc.","nameEN":"Oncternal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oncternal Therapeutics, Inc.(ONCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oncternal Therapeutics, Inc.,ONCT,Oncternal Therapeutics, Inc.股票,Oncternal Therapeutics, Inc.股票老虎,Oncternal Therapeutics, Inc.股票老虎国际,Oncternal Therapeutics, Inc.行情,Oncternal Therapeutics, Inc.股票行情,Oncternal Therapeutics, Inc.股价,Oncternal Therapeutics, Inc.股市,Oncternal Therapeutics, Inc.股票价格,Oncternal Therapeutics, Inc.股票交易,Oncternal Therapeutics, Inc.股票购买,Oncternal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oncternal Therapeutics, Inc.(ONCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}